PT-141 Ingredients: What's Inside Bremelanotide

PT-141 ingredients explained: bremelanotide peptide plus excipients like water for injection and pH adjusters, and how nasal spray formulas differ.

ARTICLE OVERVIEW

PT-141 ingredients explained: bremelanotide peptide plus excipients like water for injection and pH adjusters, and how nasal spray formulas differ.

The active ingredient in PT-141 is bremelanotide, a synthetic cyclic heptapeptide that binds melanocortin receptors in the brain. Every other component is an inactive ingredient such as water for injection, a pH adjuster, or a preservative, and that list changes depending on whether the product is an FDA-approved autoinjector, a research vial, or a compounded nasal spray. Only bremelanotide injection (Vyleesi) is FDA-approved for human use in the United States, and it is approved for premenopausal women with acquired, generalized hypoactive sexual desire disorder.

Bremelanotide: The Only Active Ingredient

Bremelanotide is built from seven amino acids: norleucine, aspartic acid, histidine, D-phenylalanine, arginine, tryptophan, and lysine. A lactam bridge between the aspartic acid and lysine locks the chain into a ring shape, which is what keeps the peptide stable against digestion.

The free base has a molecular formula of C50H68N14O10 and a molecular weight of roughly 1,025 g/mol. Finished products almost always use bremelanotide acetate, the acetate salt form, because it dissolves more easily in water than the free base does.

Bremelanotide is not a steroid, a nitrate, or a PDE5 inhibitor like sildenafil or tadalafil. It works through melanocortin-4 receptors, which is why its ingredient profile and its side effect profile both look different from standard erectile dysfunction drugs. That distinction is one of the first things people notice when they compare the pt-141 peptide for men with prescription ED pills.

PT-141 Ingredients by Product Format

Format drives the inactive ingredient list more than anything else. The table below compares the three formats most US buyers encounter.

FormatActive ingredientTypical inactive ingredientsNotes
FDA-approved injection (Vyleesi)Bremelanotide acetate, 1.75 mg per 0.3 mLWater for injection; sodium hydroxide and hydrochloric acid for pH adjustmentSingle-use autoinjector; the only FDA-approved bremelanotide product
Research-grade vialBremelanotide acetate as lyophilized powderUsually none; some batches include mannitol as a bulking agentLabeled for laboratory research only, not for human use
Compounded or DIY nasal sprayBremelanotide, often from a reconstituted vialSterile water or saline, benzyl alcohol preservative, occasional bufferNot FDA-approved; sterility and dose accuracy are the biggest variables

PT-141 Nasal Spray vs Injection: What Actually Changes

The pt-141 nasal spray vs injection comparison comes down to delivery and excipients, not to the peptide itself. Both routes ultimately place bremelanotide in the bloodstream, but the injection is a sterile, pH-buffered aqueous solution, while a nasal product needs a carrier that will not irritate the nasal lining.

Nasal formulas commonly use sterile water or normal saline as the base. Multi-dose bottles usually add benzyl alcohol as a preservative, and some include a mild buffer to hold pH between roughly 5 and 7. A pt-141 bremelanotide injection 20mg vial, by contrast, holds only lyophilized peptide powder, which is reconstituted with bacteriostatic water before a dose is drawn.

Sterility is the difference that matters most. Water that is not sterile can push bacteria directly into the nasal cavity, and nasal tissue absorbs far less peptide than subcutaneous tissue does, so the delivered dose is harder to predict.

What Should Not Be in a PT-141 Product

  • Undeclared prescription drugs such as sildenafil, tadalafil, or vardenafil.
  • Fillers, dyes, or "proprietary blends" that never state the actual peptide amount.
  • Any label claiming the product cures erectile dysfunction or replaces medical treatment.
  • Vials with no lot number, no purity test, and no manufacturer contact information.

Counterfeit and mislabeled products are a genuine problem in the research peptide market. Independent testing has repeatedly found vials that contain no active peptide at all or that are contaminated with bacteria.

Purity, Labeling, and Where to Buy PT-141

Reputable suppliers publish a certificate of analysis from a third-party lab showing HPLC purity, usually 98% or higher, along with mass spectrometry confirmation of the molecular weight. That certificate should match the lot number printed on the vial.

Most legitimate sellers label bremelanotide as a research chemical and state that it is not for human or veterinary use. Anyone researching where to buy pt-141 for personal use should understand that only the Vyleesi autoinjector carries FDA approval, and it requires a prescription.

Onset, Duration, and Dosing Reality

Pharmacokinetics are determined by the peptide, not by the excipients. After a subcutaneous injection, most users report noticing effects within 30 to 60 minutes.

Reported effects generally fade within two to six hours, although nausea, flushing, and headache can linger longer than the intended effect. Nasal use tends to produce a slower, weaker, and more variable response than injection.

Making a Nasal Spray at Home

Interest in how to make pt-141 nasal spray is usually driven by cost, but the ingredient side is the easy part. The hard parts are sterility, accurate measurement of microgram doses, and the fact that no home setup can verify peptide purity.

A homemade spray also cannot guarantee that the peptide distributes evenly through the liquid. If a dose settles unevenly, one spray can deliver far more or far less than intended, which is a real safety risk rather than a dosing inconvenience.

Safety Considerations

Bremelanotide can raise blood pressure and temporarily lower heart rate, so it is not appropriate for people with uncontrolled hypertension or known cardiovascular disease. Common side effects include nausea, flushing, headache, and injection-site reactions, and repeated use has been linked to focal hyperpigmentation of the skin and gums.

Anyone considering PT-141 in any form should talk with a healthcare professional about blood pressure monitoring, drug interactions, and whether an FDA-approved treatment is a better fit. Nothing on this page is medical advice.

Frequently Asked Questions

What are the main ingredients in PT-141?

The active ingredient is bremelanotide, a synthetic cyclic heptapeptide supplied as bremelanotide acetate. In the FDA-approved injection, the inactive ingredients are water for injection plus sodium hydroxide and hydrochloric acid for pH adjustment. Compounded nasal sprays may also contain sterile saline and benzyl alcohol as a preservative.

Is PT-141 nasal spray the same as the injection?

Both contain the same active peptide, bremelanotide, but the inactive ingredients and the delivery route differ. Only the subcutaneous autoinjector (Vyleesi) is FDA-approved for human use; nasal sprays sold online are research chemicals or compounded products that are not FDA-approved. Nasal absorption is also weaker and more variable than injection.

How long does PT-141 take to work and how long do the effects last?

Most users report effects beginning within 30 to 60 minutes after a subcutaneous injection, which is why the product is normally used about 45 minutes before anticipated activity. Reported effects usually fade within two to six hours, though side effects like nausea and flushing can last longer. Nasal use tends to start slower and produce a weaker response.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.